Mark M Moasser - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Mark M Moasser

Showing results (51-60 of 56) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 56 results.

Cancer Cytopathology|October 9, 2025

FNA biopsy of breast specimens effectively harvests cells for patient-derived organoids modeling ductal carcinoma in situJulia Ye, Nadine Goldhammer, Poonam Vohra, et al.

Oncogene|March 8, 2018

Regulation of inside-out β1-integrin activation by CDCP1Sara G Pollan, Fangjin Huang, Jamie M Sperger, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009

A phase I study of a 2-day lapatinib chemosensitization pulse preceding nanoparticle albumin-bound Paclitaxel for advanced solid malignanciesAmy J Chien, Julie A Illi, Andrew H Ko, et al.

Nature Cell Biology|June 5, 2019

Mapping phospho-catalytic dependencies of therapy-resistant tumours reveals actionable vulnerabilitiesJean-Philippe Coppé, Miki Mori, Bo Pan, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008

A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancerMaura N Dickler, Hope S Rugo, Carey A Eberle, et al.

Nature Cancer|February 9, 2023

A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAF<sup>V600E</sup> colorectal tumorsAna Ruiz-Saenz, Chloe E Atreya, Changjun Wang, et al.

Pageof 6

Search research articles

Showing results (51-60 of 56) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 56 results.

Cancer Cytopathology|October 9, 2025

FNA biopsy of breast specimens effectively harvests cells for patient-derived organoids modeling ductal carcinoma in situJulia Ye, Nadine Goldhammer, Poonam Vohra, et al.

Oncogene|March 8, 2018

Regulation of inside-out β1-integrin activation by CDCP1Sara G Pollan, Fangjin Huang, Jamie M Sperger, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009

A phase I study of a 2-day lapatinib chemosensitization pulse preceding nanoparticle albumin-bound Paclitaxel for advanced solid malignanciesAmy J Chien, Julie A Illi, Andrew H Ko, et al.

Nature Cell Biology|June 5, 2019

Mapping phospho-catalytic dependencies of therapy-resistant tumours reveals actionable vulnerabilitiesJean-Philippe Coppé, Miki Mori, Bo Pan, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008

A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancerMaura N Dickler, Hope S Rugo, Carey A Eberle, et al.

Nature Cancer|February 9, 2023

A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAF<sup>V600E</sup> colorectal tumorsAna Ruiz-Saenz, Chloe E Atreya, Changjun Wang, et al.

Pageof 6